Los Angeles Capital Management’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
Other funds holding CTKB
HA
TCM
Los Angeles Capital Management's CTKB Position: Q2 2026 in Review
Los Angeles Capital Management opened a new position in Cytek Biosciences (CTKB) in Q2 2026: 62,160 shares worth $275K. The stake represents ﹤0.01% of the portfolio and ranks #1073 among its holdings. This is a return to the name: Los Angeles Capital Management previously reported a position in CTKB as recently as Q4 2025.
Los Angeles Capital Management first reported a position in CTKB in Q2 2025 and has held it in 3 quarters since. 154 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.
- Los Angeles Capital Management held 62,160 shares of Cytek Biosciences worth $275K as of Q2 2026.
- Cytek Biosciences was a new Los Angeles Capital Management position in Q2 2026.
- Cytek Biosciences made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1073 holding.
- Los Angeles Capital Management first reported a position in Cytek Biosciences in Q2 2025 and has held it in 3 quarters since.
- 154 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.
Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.